Join date: Sep 15, 2021

0 Like Received
0 Comment Received
0 Best Answer

The selective serotonin reuptake inhibitors (SSRIs) market is poised to grow by $ 809.73 mn during 2021-2025, progressing at a CAGR of about 4% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the rising prevalence of mental illnesses. With an increase in mental illnesses, there is a rising need for effective neurological drugs. Among the various neurological drugs available in the market, SSRIs drugs have high therapeutic efficacy. This study identifies the growing geriatric population as one of the prime reasons driving the selective serotonin reuptake inhibitors (SSRIs) market growth during the next few years.



More actions